Biotech Stock News (ANAC) (CELG) (RCPT) (JUNO) (AMGN)

Anacor Pharmaceuticals (NASDAQ:ANAC) On Monday July 13, 2015 shares of Anacor went up 55%, closing around $131.93 per share after the company announced positive phase 3 results in patients who have atopic dermatitis. There were two phase 3 trials that were testing Anacor’s drug, Crisaborole, for these patients with atopic dermatitis — also known as … Read more

Analysts Provide Insight on Celgene Corporation (CELG) And Receptos Inc (RCPT) in Light of Acquisition Announcement

By Cody Miecnikowski Oncology therapy company Celgene Corporation (NASDAQ:CELG) announced a definitive agreement on July 14 to acquire Receptos Inc (NASDAQ: RCPT). Under the terms of the agreement, Celgene will pay $7.2 billion in cash for the autoimmune drug maker. The boards of both companies have approved the terms of the acquisition and expect it … Read more

Biotech Stock News (SRPT) (JUNO) (CELG) (AGTC) (VRTX)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday June 29, 2015 Sarepta had announced that it had completed¬†its rolling submission of its New Drug Application — NDA — to the FDA. A rolling submission is an FDA policy whereby biotech companies can submit their marketing approval application in small parts on a rolling basis instead of doing it … Read more

Celgene Corporation (CELG) Stock | Can It Continue To Climb

Celgene Corporation (NASDAQ: CELG) Celgene Corporation recently reported it’s earnings; and while the report was positive, the company’s stock fell. However, it seems as though we’re starting to see movement in the positive direction. So now, the big question pops up. Will CELG continue the upward momentum? Here’s what I see… What I Think The … Read more